Europe’s trickle of unrated deals contrasts with Glaxo, BP megadeals in US
Europe’s corporate bond market showed some glimmers of life today as two unrated companies announced roadshows. But these flickers are as nothing compared with the blaze of deals in the dollar market, where GlaxoSmithKline yesterday broke a three year absence from the bond market with a $5bn blowout.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts